News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Recent Study Looks at How Consumers Use Wearables That Generate Biometric data and Whether Such Data Might Be Valuable for Physicians and Medical Laboratories

Precision medicine programs can benefit from wearable usage data; however, little information has been collected on personalities and behaviors of the device users

Wearables medical devices have the potential to monitor some of the same biomarkers used in medical laboratory tests today. In addition, these mobile technologies can make it possible for clinical laboratories to monitor patients in real time, as well as allow labs to incorporate such into a patient’s historical record of lab test results.

The trend toward personalized medicine (aka, Precision Medicine) is increasing, with many payment programs based on it. Thus, monitoring and correcting activities that cause chronic disease, or work against treatments, is becoming standard procedure for forward-thinking, technically proficient doctors and hospitals. But are patients onboard with all of it?

Activity Trackers for Monitoring Patient Behavior

With the popularity of activity trackers on the rise, researchers are examining their usage patterns to determine how the devices are being utilized, their target market, and ways to encourage sustained use of the gadgets.

A recent article published in Annals of Internal Medicine provided insight regarding who is using this type of wearable device, how activity trackers are being employed, and the length of time consumers will maintain their usage.

The research was spearheaded by Mitesh Patel, MD, Assistant Professor of Medicine and Health Care Management, Perelman School of Medicine and the Wharton School, University of Pennsylvania. He believes this is the largest study of its kind to evaluate the usage of wearable fitness trackers.

“Many people are excited by the potential of using activity trackers to monitor healthy behaviors, but there is very little evidence on who is using them and whether or not use is sustained over time,” Patel stated in a Penn Medicine news release. “We found that, though use grew over time, it really varied depending on individual characteristics like age and income. We also found that once someone started using an activity tracker, sustained use at six months was high at 80%.”

Patel is also Director of the Penn Medicine Nudge Unit, a behavioral design team that is studying the impact that nudges or small interventions may have on healthcare. The team is examining ways in which nudges can influence choices, and also direct medical professionals and patients toward optimal decisions to improve healthcare delivery and results. (Photo copyright: University of Pennsylvania.)

Gaming the Study Improves Usage of Test Devices

To perform the study, 4.4 million members of a national wellness program were invited to take part in data collection. Approximately 55,000 of those individuals actually participated in the study, which involved downloading an app to record pertinent information. Researchers tracked and interpreted the data during a two-year period in 2014 and 2015.

The information analyzed included:

  • When participants initially activated their tracker;
  • How often the device was utilized;
  • The average number of steps taken per day; and,
  • Sociodemographic characteristics.

The results of the study were not entirely unexpected, but there were surprises:

  • 80% of the people who initially activated the devices were still using them after six months;
  • Only 0.2% of the invited individuals used the devices in the first year;
  • However, that number increased to 1.2% during the second year.

The usage of wearable activity trackers was nearly double among younger people than it was for older individuals. In addition, people from households with an annual income of less than $50,000 used the gadgets at lower rates than those at higher income levels.

A mere 0.1% of the potential participants were over 65-years old. However, 90% of individuals in this age group were still using the devices six months after initial activation.

The authors of the study stated that adding game elements, such as points, levels, badges and financial incentives may have played a role in the sustained use of the activity trackers.

Gamification and financial incentives are commonly used within wellness programs, but their impact has not been well studied,” Patel stated in the news release. “Our findings provide initial evidence suggesting that these types of engagement strategies may show promise for keeping sustained use high. However, more studies are needed to determine the best way to combine these types of engagement strategies with activity trackers to improve health outcomes.”

Most Commonly Used Mobile Activity Tracking Devices

There were 60 different types of wearable activity trackers that could be used by participants for the study. Seventy-six percent of those participants elected to use the FitBit activity tracker. This mobile healthcare device is worn on the wrist like a watch. It monitors activity, exercise, food, weight, and sleep to provide consumers with real-time data about their activities.

The data collected by the device is sent automatically and wirelessly to the user’s phone or computer. Individuals then can use the FitBit dashboard to view their progress through online charts and graphs. The dashboard also offers progress notifications to the consumer and gives achievement badges when established goals have been reached.

The second most common activity trackers used were Apple devices, such as Apple Watches, which were chosen by 9% of the participants.

Biometric data on patients’ behavior and activities that is collected and transmitted from mobile devices has swiftly become critical data doctors use in precision medicine diagnoses and treatments. Clinical laboratories will likely be including biomarker data taken by these devices in their testing and procedures in the future. The only question is how quickly the data generated by such devices becomes acceptable to add to a patient’s permanent health record.

—JP Schlingman

Related Information:

New Wellness Study Shows Just How Sticky Wearables Can Be, Even Among Seniors

Penn Study Shows 80% of Activity Tracker Users Stick with the Devices for at Least Six Months

Game Time: To Increase Exercise, Study Shows Gaming Strategies and a Buddy Are Key

When Push Comes to Nudge

Improvements to Fitness Wearables Help Stream Data from Consumers’ Homes to EHRs and Clinical Pathology Laboratories

Apple May Be Developing Mobile Device Technology to Monitor User’s Health and Transmit Data in Real Time

Improvements to Fitness Wearables Help Stream Data from Consumers’ Homes to EHRs and Clinical Pathology Laboratories

As technologies used by fitness wearables mature, medical laboratories will want to develop ways to access and process the flood of data that will become available

Point-of-care testing and remote patient monitoring are two technologies that could be disruptive to the clinical laboratory industry, particularly if use of these devices was to reduce the volume of patient specimen that are referred to the nation’s large, centralized medical laboratories.

This is one reason why savvy pathologists watch the stream of new products designed to allow athletes and consumers to monitor their fitness and other characteristics of good health. These devices are at the very front of the curve for remote monitoring of an athlete’s performance during training and competition, as well as enabling consumers to track different parameters of their health. What’s a toy for today’s sophisticated consumers could later be easily adopted for clinical diagnostic purposes.

One great example of how swiftly technology advances are changing remote diagnostic monitoring involves heart rate monitors. It wasn’t long ago that even basic heart rate monitors were a pricey purchase for consumers. But thanks to strong interest in gathering healthcare data, costs are dropping. (more…)

Scanadu is Preparing Consumer Self-Test Device for Review by the FDA as Part of Its Mission to Enable Patients to Monitor Their Health without the Need for Clinical Pathology Laboratory Tests

Scanadu’s device is called the ScanaFlo and is designed to collect biometric data from consumers using a variety of methods, including urine specimens

Now gathering study data needed to launch a review by the Food and Drug Administration (FDA) is a low-cost lab urinalysis device that returns results via a smartphone for conditions such as pregnancy and diabetes. More significant for pathologists and clinical laboratory executives, this handy point-of-care device is capable of doing tests for traditional medical laboratory tests, ranging from glucose and leukocytes to bilirubin and creatinine.

The device was invented at Scanadu, Inc., a health-tech startup based at NASA Ames Research Center in Mountain View, California. It is a new low-cost lab urinalysis kit that uses a smartphone to return test results on liver, kidneys, urinary tract, and metabolic functions. The company uses imaging and sound analysis, molecular diagnostics, data analytics, and a suite of algorithms to create devices that offer consumers comprehensive, real-time health data on mobile devices. (more…)

Implantable Wireless Heart Failure Management System Significantly Reduces Hospital Readmissions and May Inspire Implantable Diagnostic Test Devices

Implantable devices with this technology could be designed to perform some of the same kinds of assays currently handled in medical labs

Implantable diagnostic devices that report results wirelessly to patients’ physicians could be both a threat and an opportunity for clinical laboratories and pathology groups. News of clearance by the Food and Drug Administration (FDA) of an implantable monitoring device for home use by heart patients demonstrates that such technology is improving with rapid speed.

Could Implantable Monitoring Devices Replace Some Medical Lab Tests?

Patients use CardioMEMS from the comfort of their homes. The implantable monitoring device measures pulmonary artery pressures and heart rates and transmits that data wirelessly to physicians. It was last summer when the FDA cleared the CardioMEMS Heart Failure Management System, manufactured by St. Jude Medical of St. Paul, MN. Such implantable technology could eventually perform certain assays currently handled in medical laboratories. (more…)

Mobile Apps for Corporate Health Programs Create Great Patient Engagement and Participation

Clinical laboratories have an opportunity to provide medical laboratory test services to employer-sponsored wellness programs

Venture capitalists are beginning to pour dollars into mobile apps designed to support corporate health and wellness. For savvy pathologists and clinical laboratory managers, this represents an opportunity to serve a cash-paying market for medical laboratory testing.

Another aspect of this trend which may be worth studying by pathologists and clinical laboratory administrators is the use of “gamification” by these mobile app developers. Gamification uses technologies and programming to more deeply engage the user, just as a video game does.

Corporate wellness platform Keas of San Francisco, California, recently announced an $8-million investment round, according to a story at mobihealthnews.com. Ignition Partners and Atlas Ventures provided the capital. With this latest round of funding, investors have $25.5 million invested in Keas. (more…)

;